APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ripretinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ripretinib Market Analysis and Forecast 2026-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchRipretinib Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Ripretinib Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Ripretinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ripretinib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ripretinib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ripretinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ripretinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ripretinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ripretinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ripretinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ripretinib include Zai Lab Pharmaceutical Co., Ltd., TargetMol, MedKoo Biosciences, MedChem Express and Deciphera, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ripretinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ripretinib, also provides the sales of main regions and countries. Of the upcoming market potential for Ripretinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ripretinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ripretinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ripretinib sales, projected growth trends, production technology, application and end-user industry.

Ripretinib Segment by Company

Zai Lab Pharmaceutical Co., Ltd.

TargetMol

MedKoo Biosciences

MedChem Express

Deciphera

Ripretinib Segment by Type

Tablet

Capsule

Ripretinib Segment by Application

Gastric Stromal Tumor Treatment

Mastocytosis

Ripretinib Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ripretinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ripretinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ripretinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ripretinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ripretinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ripretinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ripretinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Capsule Major Manufacturers Table 4. Global Ripretinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Gastric Stromal Tumor Treatment Major Manufacturers Table 6. Mastocytosis Major Manufacturers Table 7. Ripretinib Industry Trends Table 8. Ripretinib Industry Drivers Table 9. Ripretinib Industry Opportunities and Challenges Table 10. Ripretinib Industry Restraints Table 11. Global Ripretinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Ripretinib Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Ripretinib Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Ripretinib Revenue Market Share by Region (2021-2026) Table 15. Global Ripretinib Revenue Market Share by Region (2027-2032) Table 16. Global Ripretinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Ripretinib Sales by Region (2021-2026) & (K Units) Table 18. Global Ripretinib Sales by Region (2027-2032) & (K Units) Table 19. Global Ripretinib Sales Market Share by Region (2021-2026) Table 20. Global Ripretinib Sales Market Share by Region (2027-2032) Table 21. Global Ripretinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Ripretinib Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Ripretinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ripretinib Sales Market Share by Manufacturers (2021-2026) Table 25. Global Ripretinib Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Ripretinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Ripretinib Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Ripretinib Manufacturers, Product Type & Application Table 29. Global Ripretinib Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Ripretinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Ripretinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ripretinib Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Ripretinib Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Ripretinib Revenue Market Share by Type (2021-2026) Table 36. Global Ripretinib Revenue Market Share by Type (2027-2032) Table 37. Global Ripretinib Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Ripretinib Sales by Type (2021-2026) & (K Units) Table 39. Global Ripretinib Sales by Type (2027-2032) & (K Units) Table 40. Global Ripretinib Sales Market Share by Type (2021-2026) Table 41. Global Ripretinib Sales Market Share by Type (2027-2032) Table 42. Global Ripretinib Price by Type (2021-2026) & (US$/Unit) Table 43. Global Ripretinib Price by Type (2027-2032) & (US$/Unit) Table 44. Global Ripretinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Ripretinib Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Ripretinib Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Ripretinib Revenue Market Share by Application (2021-2026) Table 48. Global Ripretinib Revenue Market Share by Application (2027-2032) Table 49. Global Ripretinib Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Ripretinib Sales by Application (2021-2026) & (K Units) Table 51. Global Ripretinib Sales by Application (2027-2032) & (K Units) Table 52. Global Ripretinib Sales Market Share by Application (2021-2026) Table 53. Global Ripretinib Sales Market Share by Application (2027-2032) Table 54. Global Ripretinib Price by Application (2021-2026) & (US$/Unit) Table 55. Global Ripretinib Price by Application (2027-2032) & (US$/Unit) Table 56. Zai Lab Pharmaceutical Co., Ltd. Company Information Table 57. Zai Lab Pharmaceutical Co., Ltd. Business Overview Table 58. Zai Lab Pharmaceutical Co., Ltd. Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Zai Lab Pharmaceutical Co., Ltd. Ripretinib Product Portfolio Table 60. Zai Lab Pharmaceutical Co., Ltd. Recent Development Table 61. TargetMol Company Information Table 62. TargetMol Business Overview Table 63. TargetMol Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. TargetMol Ripretinib Product Portfolio Table 65. TargetMol Recent Development Table 66. MedKoo Biosciences Company Information Table 67. MedKoo Biosciences Business Overview Table 68. MedKoo Biosciences Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. MedKoo Biosciences Ripretinib Product Portfolio Table 70. MedKoo Biosciences Recent Development Table 71. MedChem Express Company Information Table 72. MedChem Express Business Overview Table 73. MedChem Express Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. MedChem Express Ripretinib Product Portfolio Table 75. MedChem Express Recent Development Table 76. Deciphera Company Information Table 77. Deciphera Business Overview Table 78. Deciphera Ripretinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Deciphera Ripretinib Product Portfolio Table 80. Deciphera Recent Development Table 81. North America Ripretinib Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Ripretinib Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Ripretinib Sales by Type (2021-2026) & (K Units) Table 84. North America Ripretinib Sales by Type (2027-2032) & (K Units) Table 85. North America Ripretinib Sales Price by Type (2021-2026) & (US$/Unit) Table 86. North America Ripretinib Sales Price by Type (2027-2032) & (US$/Unit) Table 87. North America Ripretinib Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Ripretinib Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Ripretinib Sales by Application (2021-2026) & (K Units) Table 90. North America Ripretinib Sales by Application (2027-2032) & (K Units) Table 91. North America Ripretinib Sales Price by Application (2021-2026) & (US$/Unit) Table 92. North America Ripretinib Sales Price by Application (2027-2032) & (US$/Unit) Table 93. North America Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Ripretinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Ripretinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Ripretinib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 97. North America Ripretinib Sales by Country (2021-2026) & (K Units) Table 98. North America Ripretinib Sales by Country (2027-2032) & (K Units) Table 99. North America Ripretinib Sales Price by Country (2021-2026) & (US$/Unit) Table 100. North America Ripretinib Sales Price by Country (2027-2032) & (US$/Unit) Table 101. United States Ripretinib Revenue (2021-2032) & (US$ Million) Table 102. Canada Ripretinib Revenue (2021-2032) & (US$ Million) Table 103. Europe Ripretinib Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Ripretinib Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Ripretinib Sales by Type (2021-2026) & (K Units) Table 106. Europe Ripretinib Sales by Type (2027-2032) & (K Units) Table 107. Europe Ripretinib Sales Price by Type (2021-2026) & (US$/Unit) Table 108. Europe Ripretinib Sales Price by Type (2027-2032) & (US$/Unit) Table 109. Europe Ripretinib Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Ripretinib Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Ripretinib Sales by Application (2021-2026) & (K Units) Table 112. Europe Ripretinib Sales by Application (2027-2032) & (K Units) Table 113. Europe Ripretinib Sales Price by Application (2021-2026) & (US$/Unit) Table 114. Europe Ripretinib Sales Price by Application (2027-2032) & (US$/Unit) Table 115. Europe Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Ripretinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. Europe Ripretinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. Europe Ripretinib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 119. Europe Ripretinib Sales by Country (2021-2026) & (K Units) Table 120. Europe Ripretinib Sales by Country (2027-2032) & (K Units) Table 121. Europe Ripretinib Sales Price by Country (2021-2026) & (US$/Unit) Table 122. Europe Ripretinib Sales Price by Country (2027-2032) & (US$/Unit) Table 123. Germany Ripretinib Revenue (2021-2032) & (US$ Million) Table 124. France Ripretinib Revenue (2021-2032) & (US$ Million) Table 125. U.K. Ripretinib Revenue (2021-2032) & (US$ Million) Table 126. Italy Ripretinib Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Ripretinib Revenue (2021-2032) & (US$ Million) Table 128. China Ripretinib Revenue by Type (2021-2026) & (US$ Million) Table 129. China Ripretinib Revenue by Type (2027-2032) & (US$ Million) Table 130. China Ripretinib Sales by Type (2021-2026) & (K Units) Table 131. China Ripretinib Sales by Type (2027-2032) & (K Units) Table 132. China Ripretinib Sales Price by Type (2021-2026) & (US$/Unit) Table 133. China Ripretinib Sales Price by Type (2027-2032) & (US$/Unit) Table 134. China Ripretinib Revenue by Application (2021-2026) & (US$ Million) Table 135. China Ripretinib Revenue by Application (2027-2032) & (US$ Million) Table 136. China Ripretinib Sales by Application (2021-2026) & (K Units) Table 137. China Ripretinib Sales by Application (2027-2032) & (K Units) Table 138. China Ripretinib Sales Price by Application (2021-2026) & (US$/Unit) Table 139. China Ripretinib Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Asia Ripretinib Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Ripretinib Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Ripretinib Sales by Type (2021-2026) & (K Units) Table 143. Asia Ripretinib Sales by Type (2027-2032) & (K Units) Table 144. Asia Ripretinib Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Asia Ripretinib Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Asia Ripretinib Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia Ripretinib Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Ripretinib Sales by Application (2021-2026) & (K Units) Table 149. Asia Ripretinib Sales by Application (2027-2032) & (K Units) Table 150. Asia Ripretinib Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Asia Ripretinib Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Ripretinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Asia Ripretinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Asia Ripretinib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 156. Asia Ripretinib Sales by Country (2021-2026) & (K Units) Table 157. Asia Ripretinib Sales by Country (2027-2032) & (K Units) Table 158. Asia Ripretinib Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Asia Ripretinib Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Japan Ripretinib Revenue (2021-2032) & (US$ Million) Table 161. South Korea Ripretinib Revenue (2021-2032) & (US$ Million) Table 162. India Ripretinib Revenue (2021-2032) & (US$ Million) Table 163. Australia Ripretinib Revenue (2021-2032) & (US$ Million) Table 164. China Taiwan Ripretinib Revenue (2021-2032) & (US$ Million) Table 165. Southeast Asia Ripretinib Revenue (2021-2032) & (US$ Million) Table 166. SAMEA Ripretinib Revenue by Type (2021-2026) & (US$ Million) Table 167. SAMEA Ripretinib Revenue by Type (2027-2032) & (US$ Million) Table 168. SAMEA Ripretinib Sales by Type (2021-2026) & (K Units) Table 169. SAMEA Ripretinib Sales by Type (2027-2032) & (K Units) Table 170. SAMEA Ripretinib Sales Price by Type (2021-2026) & (US$/Unit) Table 171. SAMEA Ripretinib Sales Price by Type (2027-2032) & (US$/Unit) Table 172. SAMEA Ripretinib Revenue by Application (2021-2026) & (US$ Million) Table 173. SAMEA Ripretinib Revenue by Application (2027-2032) & (US$ Million) Table 174. SAMEA Ripretinib Sales by Application (2021-2026) & (K Units) Table 175. SAMEA Ripretinib Sales by Application (2027-2032) & (K Units) Table 176. SAMEA Ripretinib Sales Price by Application (2021-2026) & (US$/Unit) Table 177. SAMEA Ripretinib Sales Price by Application (2027-2032) & (US$/Unit) Table 178. SAMEA Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. SAMEA Ripretinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. SAMEA Ripretinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. SAMEA Ripretinib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 182. SAMEA Ripretinib Sales by Country (2021-2026) & (K Units) Table 183. SAMEA Ripretinib Sales by Country (2027-2032) & (K Units) Table 184. SAMEA Ripretinib Sales Price by Country (2021-2026) & (US$/Unit) Table 185. SAMEA Ripretinib Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Brazil Ripretinib Revenue (2021-2032) & (US$ Million) Table 187. Argentina Ripretinib Revenue (2021-2032) & (US$ Million) Table 188. Chile Ripretinib Revenue (2021-2032) & (US$ Million) Table 189. Colombia Ripretinib Revenue (2021-2032) & (US$ Million) Table 190. Peru Ripretinib Revenue (2021-2032) & (US$ Million) Table 191. Saudi Arabia Ripretinib Revenue (2021-2032) & (US$ Million) Table 192. Israel Ripretinib Revenue (2021-2032) & (US$ Million) Table 193. UAE Ripretinib Revenue (2021-2032) & (US$ Million) Table 194. Turkey Ripretinib Revenue (2021-2032) & (US$ Million) Table 195. Iran Ripretinib Revenue (2021-2032) & (US$ Million) Table 196. Egypt Ripretinib Revenue (2021-2032) & (US$ Million) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Ripretinib Distributors List Table 200. Ripretinib Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Ripretinib Image Figure 2. Global Ripretinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ripretinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Capsule Image Figure 6. Global Ripretinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ripretinib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Gastric Stromal Tumor Treatment Image Figure 9. Mastocytosis Image Figure 10. Global Ripretinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Ripretinib Revenue (2021-2032) & (US$ Million) Figure 12. Global Ripretinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Ripretinib Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Ripretinib Revenue Market Share by Region (2021-2032) Figure 15. Global Ripretinib Sales (2021-2032) & (K Units) Figure 16. Global Ripretinib Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Ripretinib Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Ripretinib Sales YoY (2021-2032) & (K Units) Figure 19. Europe Ripretinib Sales YoY (2021-2032) & (K Units) Figure 20. China Ripretinib Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Ripretinib Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Ripretinib Sales YoY (2021-2032) & (K Units) Figure 23. Global Ripretinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Ripretinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Ripretinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ripretinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Ripretinib Revenue Market Share by Type (2021-2032) Figure 29. Global Ripretinib Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Ripretinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ripretinib Sales Market Share by Type (2021-2032) Figure 32. Global Ripretinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Ripretinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Ripretinib Revenue Market Share by Application (2021-2032) Figure 35. Global Ripretinib Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Ripretinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ripretinib Sales Market Share by Application (2021-2032) Figure 38. North America Ripretinib Revenue Share by Type (2021-2032) Figure 39. North America Ripretinib Sales Share by Type (2021-2032) Figure 40. North America Ripretinib Revenue Share by Application (2021-2032) Figure 41. North America Ripretinib Sales Share by Application (2021-2032) Figure 42. North America Ripretinib Revenue Share by Country (2021-2032) Figure 43. North America Ripretinib Sales Share by Country (2021-2032) Figure 44. Europe Ripretinib Revenue Share by Type (2021-2032) Figure 45. Europe Ripretinib Sales Share by Type (2021-2032) Figure 46. Europe Ripretinib Revenue Share by Application (2021-2032) Figure 47. Europe Ripretinib Sales Share by Application (2021-2032) Figure 48. Europe Ripretinib Revenue Share by Country (2021-2032) Figure 49. Europe Ripretinib Sales Share by Country (2021-2032) Figure 50. China Ripretinib Revenue Share by Type (2021-2032) Figure 51. China Ripretinib Sales Share by Type (2021-2032) Figure 52. China Ripretinib Revenue Share by Application (2021-2032) Figure 53. China Ripretinib Sales Share by Application (2021-2032) Figure 54. Asia Ripretinib Revenue Share by Type (2021-2032) Figure 55. Asia Ripretinib Sales Share by Type (2021-2032) Figure 56. Asia Ripretinib Revenue Share by Application (2021-2032) Figure 57. Asia Ripretinib Sales Share by Application (2021-2032) Figure 58. Asia Ripretinib Revenue Share by Country (2021-2032) Figure 59. Asia Ripretinib Sales Share by Country (2021-2032) Figure 60. SAMEA Ripretinib Revenue Share by Type (2021-2032) Figure 61. SAMEA Ripretinib Sales Share by Type (2021-2032) Figure 62. SAMEA Ripretinib Revenue Share by Application (2021-2032) Figure 63. SAMEA Ripretinib Sales Share by Application (2021-2032) Figure 64. SAMEA Ripretinib Revenue Share by Country (2021-2032) Figure 65. SAMEA Ripretinib Sales Share by Country (2021-2032) Figure 66. Ripretinib Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ripretinib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Gastric Stromal Tumor Treatment
  • Mastocytosis
Companies covered
  • Zai Lab Pharmaceutical Co., Ltd.
  • TargetMol
  • MedKoo Biosciences
  • MedChem Express
  • Deciphera

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ripretinib Market by Type
  3. 1.2.1 Global Ripretinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Capsule
  6. 1.3 Ripretinib Market by Application
  7. 1.3.1 Global Ripretinib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Gastric Stromal Tumor Treatment
  9. 1.3.3 Mastocytosis
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ripretinib Market Dynamics
  1. 2.1 Ripretinib Industry Trends
  2. 2.2 Ripretinib Industry Drivers
  3. 2.3 Ripretinib Industry Opportunities and Challenges
  4. 2.4 Ripretinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ripretinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ripretinib Revenue by Region
  3. 3.2.1 Global Ripretinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ripretinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Ripretinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Ripretinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ripretinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ripretinib Sales by Region
  9. 3.4.1 Global Ripretinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ripretinib Sales by Region (2021-2026)
  11. 3.4.3 Global Ripretinib Sales by Region (2027-2032)
  12. 3.4.4 Global Ripretinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ripretinib Revenue by Manufacturers
  2. 4.1.1 Global Ripretinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ripretinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ripretinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ripretinib Sales by Manufacturers
  6. 4.2.1 Global Ripretinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ripretinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ripretinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ripretinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ripretinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ripretinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ripretinib Manufacturers, Product Type & Application
  13. 4.7 Global Ripretinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ripretinib Market CR5 and HHI
  16. 4.8.2 2025 Ripretinib Tier 1, Tier 2, and Tier 3
5 Ripretinib Market by Type
  1. 5.1 Global Ripretinib Revenue by Type
  2. 5.1.1 Global Ripretinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ripretinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ripretinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ripretinib Sales by Type
  6. 5.2.1 Global Ripretinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ripretinib Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ripretinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ripretinib Price by Type
6 Ripretinib Market by Application
  1. 6.1 Global Ripretinib Revenue by Application
  2. 6.1.1 Global Ripretinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ripretinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ripretinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ripretinib Sales by Application
  6. 6.2.1 Global Ripretinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ripretinib Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ripretinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ripretinib Price by Application
7 Company Profiles
  1. 7.1 Zai Lab Pharmaceutical Co., Ltd.
  2. 7.1.1 Zai Lab Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Zai Lab Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Zai Lab Pharmaceutical Co., Ltd. Ripretinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zai Lab Pharmaceutical Co., Ltd. Ripretinib Product Portfolio
  6. 7.1.5 Zai Lab Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 TargetMol
  8. 7.2.1 TargetMol Company Information
  9. 7.2.2 TargetMol Business Overview
  10. 7.2.3 TargetMol Ripretinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TargetMol Ripretinib Product Portfolio
  12. 7.2.5 TargetMol Recent Developments
  13. 7.3 MedKoo Biosciences
  14. 7.3.1 MedKoo Biosciences Company Information
  15. 7.3.2 MedKoo Biosciences Business Overview
  16. 7.3.3 MedKoo Biosciences Ripretinib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 MedKoo Biosciences Ripretinib Product Portfolio
  18. 7.3.5 MedKoo Biosciences Recent Developments
  19. 7.4 MedChem Express
  20. 7.4.1 MedChem Express Company Information
  21. 7.4.2 MedChem Express Business Overview
  22. 7.4.3 MedChem Express Ripretinib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MedChem Express Ripretinib Product Portfolio
  24. 7.4.5 MedChem Express Recent Developments
  25. 7.5 Deciphera
  26. 7.5.1 Deciphera Company Information
  27. 7.5.2 Deciphera Business Overview
  28. 7.5.3 Deciphera Ripretinib Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Deciphera Ripretinib Product Portfolio
  30. 7.5.5 Deciphera Recent Developments
8 North America
  1. 8.1 North America Ripretinib Market Size by Type
  2. 8.1.1 North America Ripretinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Ripretinib Sales by Type (2021-2032)
  4. 8.1.3 North America Ripretinib Price by Type (2021-2032)
  5. 8.2 North America Ripretinib Market Size by Application
  6. 8.2.1 North America Ripretinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Ripretinib Sales by Application (2021-2032)
  8. 8.2.3 North America Ripretinib Price by Application (2021-2032)
  9. 8.3 North America Ripretinib Market Size by Country
  10. 8.3.1 North America Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ripretinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ripretinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Ripretinib Market Size by Type
  2. 9.1.1 Europe Ripretinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ripretinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Ripretinib Price by Type (2021-2032)
  5. 9.2 Europe Ripretinib Market Size by Application
  6. 9.2.1 Europe Ripretinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ripretinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Ripretinib Price by Application (2021-2032)
  9. 9.3 Europe Ripretinib Market Size by Country
  10. 9.3.1 Europe Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ripretinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ripretinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Ripretinib Market Size by Type
  2. 10.1.1 China Ripretinib Revenue by Type (2021-2032)
  3. 10.1.2 China Ripretinib Sales by Type (2021-2032)
  4. 10.1.3 China Ripretinib Price by Type (2021-2032)
  5. 10.2 China Ripretinib Market Size by Application
  6. 10.2.1 China Ripretinib Revenue by Application (2021-2032)
  7. 10.2.2 China Ripretinib Sales by Application (2021-2032)
  8. 10.2.3 China Ripretinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ripretinib Market Size by Type
  2. 11.1.1 Asia Ripretinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ripretinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Ripretinib Price by Type (2021-2032)
  5. 11.2 Asia Ripretinib Market Size by Application
  6. 11.2.1 Asia Ripretinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ripretinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Ripretinib Price by Application (2021-2032)
  9. 11.3 Asia Ripretinib Market Size by Country
  10. 11.3.1 Asia Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ripretinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ripretinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ripretinib Market Size by Type
  2. 12.1.1 SAMEA Ripretinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ripretinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ripretinib Price by Type (2021-2032)
  5. 12.2 SAMEA Ripretinib Market Size by Application
  6. 12.2.1 SAMEA Ripretinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ripretinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ripretinib Price by Application (2021-2032)
  9. 12.3 SAMEA Ripretinib Market Size by Country
  10. 12.3.1 SAMEA Ripretinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ripretinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ripretinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ripretinib Value Chain Analysis
  2. 13.1.1 Ripretinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ripretinib Production Mode & Process
  6. 13.2 Ripretinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ripretinib Distributors
  9. 13.2.3 Ripretinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst